Figure 1
Flow diagram of the study patients. GnP gemcitabine plus nab–paclitaxel, GEM gemcitabine, NFF nanoliposomal irinotecan with fluorouracil folinic acid.
Figure 1 | Scientific Reports
Flow diagram of the study patients. GnP gemcitabine plus nab–paclitaxel, GEM gemcitabine, NFF nanoliposomal irinotecan with fluorouracil folinic acid.
